Polypill with or without Aspirin in Persons without Cardiovascular Disease

Participants without cardiovascular disease who were at increased risk were randomly assigned to receive a polypill (containing a statin and three blood-pressure–lowering drugs) or placebo and to receive aspirin or placebo. At 4.6 years, the incidence of cardiovascular events was lower among partici...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The New England journal of medicine Ročník 384; číslo 3; s. 216 - 228
Hlavní autori: Yusuf, Salim, Joseph, Philip, Dans, Antonio, Gao, Peggy, Teo, Koon, Xavier, Denis, López-Jaramillo, Patricio, Yusoff, Khalid, Santoso, Anwar, Gamra, Habib, Talukder, Shamim, Christou, Courtney, Girish, Preeti, Yeates, Karen, Xavier, Freeda, Dagenais, Gilles, Rocha, Catalina, McCready, Tara, Tyrwhitt, Jessica, Bosch, Jackie, Pais, Prem
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Massachusetts Medical Society 21.01.2021
Predmet:
Aged
Anticholesteremic Agents - administration & dosage
Anticholesteremic Agents - adverse effects
Antihypertensive Agents - administration & dosage
Antihypertensive Agents - adverse effects
Aspirin
Aspirin - therapeutic use
Atenolol
Atenolol - administration & dosage
Blood pressure
Blood Pressure - drug effects
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - mortality
Cardiovascular Diseases - prevention & control
Cerebral infarction
Cholesterol
Cholesterol, LDL - blood
Confidence intervals
Congestive heart failure
Drug Combinations
Drug dosages
Drug Therapy, Combination
Female
Heart attacks
Humans
Hydrochlorothiazide
Hydrochlorothiazide - administration & dosage
Hypotension
Incidence
Lipids
Male
Medication Adherence
Middle Aged
Myocardial infarction
Pharmaceuticals
Placebos
Platelet Aggregation Inhibitors - therapeutic use
Risk Factors
Simvastatin
Simvastatin - administration & dosage
Statins
Statistical analysis
Stroke
Vitamin D
ISSN:0028-4793, 1533-4406, 1533-4406
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Participants without cardiovascular disease who were at increased risk were randomly assigned to receive a polypill (containing a statin and three blood-pressure–lowering drugs) or placebo and to receive aspirin or placebo. At 4.6 years, the incidence of cardiovascular events was lower among participants receiving both the polypill and aspirin than among those receiving both placebos.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
A complete list of investigators in TIPS-3 (the International Polycap Study 3) is provided in the Supplementary Appendix, available at NEJM.org.
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa2028220